PYPL vs SYRE · P/E 7.9, rev $33.17B vs $7.60B cap
PayPal Holdings Inc (PYPL) versus Spyre Therapeutics Inc. (SYRE) — a side-by-side from cached financials, not a winner call.
PayPal Holdings Inc (PYPL) is a credit services company listed on NASDAQ. It is led by Alex Chriss.
Spyre Therapeutics Inc. (SYRE) is a biotechnology company listed on NASDAQ.
Latest reported PYPL revenue for 2025-12-31 was $33.17B. Net income was $5.23B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. PYPL currently screens at market cap $37.12B and trailing P/E 7.9.
Latest reported SYRE revenue for 2025-12-31 was $0. Net income was -$155.2M. SYRE currently screens at market cap $7.60B.
PYPL currently screens at market cap $37.12B and trailing P/E 7.9. SYRE currently screens at market cap $7.60B.
Not investment advice. Open the PYPL and SYRE stock pages for the full models.
Not investment advice.